Fluarix Tetra 15 µg / 0.5 ml Sospensione iniettabile

Land: Zwitserland

Taal: Italiaans

Bron: Swissmedic (Swiss Agency for Therapeutic Products)

Koop het nu

Werkstoffen:

haemagglutininum influenzae di tipo A (H1N1) (Virus Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus IVR-190 derivato da A/Brisbane/02/2018), haemagglutininum influenzae A (H3N2) (Virus Stamm A/Kansas/14/2017 (H3N2)-come: reassortant virus NYMC X-327 derivato da A/Kansas/14/0217), haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-come: reassortant virus B/Veneto/15/2016 NYMC BX-69A (Victoria lignaggio))

Beschikbaar vanaf:

GlaxoSmithKline AG

ATC-code:

J07BB02

INN (Algemene Internationale Benaming):

haemagglutininum influenzae A (H1N1) (Virus Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus IVR-190 derived from A/Brisbane/02/2018), haemagglutininum influenzae A (H3N2) (Virus Stamm A/Kansas/14/2017 (H3N2)-like: reassortant virus NYMC X-327 derived from A/Kansas/14/0217), haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant virus B/Maryland/15/2016 NYMC BX-69A (Victoria lineage))

farmaceutische vorm:

Sospensione iniettabile

Samenstelling:

haemagglutininum influenzae di tipo A (H1N1) (Virus Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus IVR-190 derivato da A/Brisbane/02/2018) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Kansas/14/2017 (H3N2)-come: reassortant virus NYMC X-327 derivato da A/Kansas/14/0217) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-come: reassortant virus (B/Veneto/15/2016 NYMC BX-69A (Victoria lignaggio)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013 (Yamagata lignaggio)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesio chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alfa-tocopheroli hydrogenosuccinas, il resto: ovalbuminum max. 0,05 µg, formaldehydum max. 5 µg, natrii desoxycholas max. 65 µg, gentamicini sulfas nulla, hydrocortisonum nulla, l'acqua ad iniectabilia q.s. la sospensione 0,5 ml.

klasse:

B

Therapeutische categorie:

Vaccini

Therapeutisch gebied:

Immunizzazione attiva contro l'Influenza, a partire da 36 Mesi

Autorisatie datum:

2014-05-28

Documenten in andere talen

Productkenmerken Productkenmerken Duits 03-06-2024
Productkenmerken Productkenmerken Frans 01-09-2019